speb/financial-data huggingface dataset:
EKG.V balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 51341.00
EKG.V balance_sheet (annual, 2024-12-31) — Current Assets: 158013.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Current Assets: 158013.00
EKG.V balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 24414.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 24414.00
EKG.V balance_sheet (annual, 2024-12-31) — Current Debt: 231000.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Current Debt: 231000.00
EKG.V balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 255414.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 255414.00
EKG.V balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 130700.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 130700.00
EKG.V balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 130700.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 130700.00
EKG.V balance_sheet (annual, 2024-12-31) — Current Liabilities: 468770.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 468770.00
EKG.V balance_sheet (annual, 2024-12-31) — Current Notes Payable: 231000.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Current Notes Payable: 231000.00
EKG.V cash_flow (annual, 2024-12-31) — Depreciation: 28987.00
EKG.V cash_flow (quarterly, 2024-12-31) — Depreciation: 7867.00
EKG.V cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 28987.00
EKG.V cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 7867.00
EKG.V income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 28987.00
EKG.V income_statement (quarterly, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 7867.00
EKG.V cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 28987.00
EKG.V cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 7867.00
EKG.V income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 28987.00
EKG.V income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 7867.00
EKG.V income_statement (annual, 2024-12-31) — Depreciation Income Statement: 28987.00
EKG.V income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 7867.00
EKG.V income_statement (annual, 2024-12-31) — Diluted Average Shares: 171203270.00
EKG.V income_statement (annual, 2024-12-31) — Diluted EPS: 0.00
EKG.V income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -194576.00
EKG.V income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -92674.00
EKG.V income_statement (annual, 2024-12-31) — EBIT: -156646.00
EKG.V income_statement (quarterly, 2024-12-31) — EBIT: 86257.00
EKG.V income_statement (annual, 2024-12-31) — EBITDA: -127659.00
EKG.V income_statement (quarterly, 2024-12-31) — EBITDA: 94124.00
EKG.V cash_flow (annual, 2024-12-31) — End Cash Position: 64040.00
EKG.V cash_flow (quarterly, 2024-12-31) — End Cash Position: 64040.00
EKG.V cash_flow (annual, 2024-12-31) — Financing Cash Flow: 88763.00
EKG.V cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: 38013.00
EKG.V balance_sheet (annual, 2024-12-31) — Finished Goods: 27189.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Finished Goods: 27189.00
EKG.V cash_flow (annual, 2024-12-31) — Free Cash Flow: -115664.00
EKG.V cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -51006.00
EKG.V income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -583.00
EKG.V income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: -9393.00
EKG.V balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 4371249.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 4371249.00
EKG.V income_statement (annual, 2024-12-31) — General And Administrative Expense: 638169.00
EKG.V income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 194146.00
EKG.V balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 66993.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 66993.00
EKG.V balance_sheet (annual, 2024-12-31) — Gross PPE: 785907.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Gross PPE: 785907.00
EKG.V income_statement (annual, 2024-12-31) — Gross Profit: 507832.00
EKG.V income_statement (quarterly, 2024-12-31) — Gross Profit: 155767.00
EKG.V income_statement (annual, 2024-12-31) — Insurance And Claims: 74469.00
EKG.V income_statement (quarterly, 2024-12-31) — Insurance And Claims: 16549.00
EKG.V income_statement (annual, 2024-12-31) — Interest Expense: 37930.00
EKG.V income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 37930.00
EKG.V cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 6400.00
EKG.V balance_sheet (annual, 2024-12-31) — Interest Payable: 8518.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Interest Payable: 8518.00
EKG.V balance_sheet (annual, 2024-12-31) — Inventory: 27189.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Inventory: 27189.00
EKG.V balance_sheet (annual, 2024-12-31) — Invested Capital: -45578.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Invested Capital: -45578.00
EKG.V cash_flow (annual, 2024-12-31) — Investing Cash Flow: -5004.00
EKG.V cash_flow (annual, 2024-12-31) — Issuance Of Debt: 155763.00
EKG.V cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 44763.00
EKG.V balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 26440.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 26440.00
EKG.V balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 26440.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 26440.00
EKG.V cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 155763.00
EKG.V cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -27000.00
EKG.V cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -6750.00
EKG.V balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 737359.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 737359.00
EKG.V balance_sheet (annual, 2024-12-31) — Net Debt: 166960.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Net Debt: 166960.00
EKG.V income_statement (annual, 2024-12-31) — Net Income: -194576.00
EKG.V income_statement (quarterly, 2024-12-31) — Net Income: -92674.00
EKG.V income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -194576.00
EKG.V income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -92674.00
EKG.V income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -194576.00
EKG.V income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -92674.00
EKG.V income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -194576.00
EKG.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -92674.00
EKG.V income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -194576.00
EKG.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -92674.00
EKG.V cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -194576.00
EKG.V cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -92674.00
EKG.V income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -194576.00
EKG.V income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -92674.00
EKG.V income_statement (annual, 2024-12-31) — Net Interest Income: -37930.00
EKG.V cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 88763.00
EKG.V cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 38013.00
EKG.V cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 128763.00
EKG.V cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 149013.00
EKG.V income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -37930.00
EKG.V balance_sheet (annual, 2024-12-31) — Net PPE: 60619.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Net PPE: 60619.00
EKG.V cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -5004.00
EKG.V cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -40000.00
EKG.V cash_flow (quarterly, 2024-12-31) — Net Short Term Debt Issuance: -111000.00
EKG.V balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -276578.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: -276578.00
EKG.V income_statement (annual, 2024-12-31) — Normalized EBITDA: -97110.00
EKG.V income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 133483.00
EKG.V income_statement (annual, 2024-12-31) — Normalized Income: -164027.00
EKG.V income_statement (quarterly, 2024-12-31) — Normalized Income: -53315.00
EKG.V cash_flow (annual, 2024-12-31) — Operating Cash Flow: -110660.00
EKG.V cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -46002.00
EKG.V income_statement (annual, 2024-12-31) — Operating Income: -261164.00
EKG.V income_statement (quarterly, 2024-12-31) — Operating Income: -18261.00
EKG.V income_statement (annual, 2024-12-31) — Operating Revenue: 526676.00
EKG.V income_statement (quarterly, 2024-12-31) — Operating Revenue: 170391.00
EKG.V balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 193074006.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 193074006.00
EKG.V balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 4371249.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 4371249.00
EKG.V balance_sheet (annual, 2024-12-31) — Other Equity Interest: 149690.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 149690.00
EKG.V income_statement (annual, 2024-12-31) — Other Gand A: 113789.00
EKG.V income_statement (quarterly, 2024-12-31) — Other Gand A: 62796.00
EKG.V income_statement (annual, 2024-12-31) — Other Income Expense: 104518.00
EKG.V income_statement (quarterly, 2024-12-31) — Other Income Expense: -36483.00
EKG.V cash_flow (annual, 2024-12-31) — Other Non Cash Items: 31530.00
EKG.V cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 27591.00
EKG.V income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 135067.00
EKG.V income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 2876.00
EKG.V income_statement (annual, 2024-12-31) — Other Operating Expenses: 101840.00
EKG.V income_statement (quarterly, 2024-12-31) — Other Operating Expenses: -27985.00
EKG.V balance_sheet (annual, 2024-12-31) — Payables: 31315.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Payables: 31315.00
EKG.V balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 82656.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 82656.00
EKG.V balance_sheet (annual, 2024-12-31) — Prepaid Assets: 25753.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 25753.00
EKG.V income_statement (annual, 2024-12-31) — Pretax Income: -194576.00
EKG.V income_statement (quarterly, 2024-12-31) — Pretax Income: -92674.00
EKG.V balance_sheet (annual, 2024-12-31) — Properties: 0.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
EKG.V cash_flow (annual, 2024-12-31) — Purchase Of PPE: -5004.00
EKG.V balance_sheet (annual, 2024-12-31) — Receivables: 41031.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Receivables: 41031.00
EKG.V income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 18844.00
EKG.V income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 14624.00
EKG.V income_statement (annual, 2024-12-31) — Reconciled Depreciation: 28987.00
EKG.V income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 7867.00
EKG.V cash_flow (annual, 2024-12-31) — Repayment Of Debt: -67000.00
EKG.V cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -6750.00
EKG.V balance_sheet (annual, 2024-12-31) — Retained Earnings: -35446202.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -35446202.00
EKG.V income_statement (annual, 2024-12-31) — Salaries And Wages: 449911.00
EKG.V income_statement (quarterly, 2024-12-31) — Salaries And Wages: 114801.00
EKG.V income_statement (annual, 2024-12-31) — Selling General And Administration: 638169.00
EKG.V income_statement (quarterly, 2024-12-31) — Selling General And Administration: 194146.00
EKG.V balance_sheet (annual, 2024-12-31) — Share Issued: 193074006.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Share Issued: 193074006.00
EKG.V cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -40000.00
EKG.V cash_flow (quarterly, 2024-12-31) — Short Term Debt Payments: 0.00
EKG.V income_statement (annual, 2024-12-31) — Special Income Charges: -29966.00
EKG.V cash_flow (annual, 2024-12-31) — Stock Based Compensation: 3554.00
EKG.V cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: -33.00
EKG.V balance_sheet (annual, 2024-12-31) — Stockholders Equity: -276578.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: -276578.00
EKG.V balance_sheet (annual, 2024-12-31) — Tangible Book Value: -276578.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -276578.00
EKG.V income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
EKG.V income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
EKG.V income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
EKG.V income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.00
EKG.V balance_sheet (annual, 2024-12-31) — Taxes Receivable: 10514.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 10514.00
EKG.V balance_sheet (annual, 2024-12-31) — Total Assets: 218632.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Total Assets: 218632.00
EKG.V balance_sheet (annual, 2024-12-31) — Total Capitalization: -276578.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Total Capitalization: -276578.00
EKG.V balance_sheet (annual, 2024-12-31) — Total Debt: 281854.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Total Debt: 281854.00
EKG.V balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -276578.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: -276578.00
EKG.V income_statement (annual, 2024-12-31) — Total Expenses: 787840.00
EKG.V income_statement (quarterly, 2024-12-31) — Total Expenses: 188652.00
EKG.V balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 495210.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 495210.00
EKG.V balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 60619.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 60619.00
EKG.V balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 26440.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 26440.00
EKG.V income_statement (annual, 2024-12-31) — Total Unusual Items: -30549.00
EKG.V income_statement (quarterly, 2024-12-31) — Total Unusual Items: -39359.00
EKG.V income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -30549.00
EKG.V income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -39359.00
EKG.V balance_sheet (annual, 2024-12-31) — Working Capital: -310757.00
EKG.V balance_sheet (quarterly, 2024-12-31) — Working Capital: -310757.00
EKG.V income_statement (annual, 2024-12-31) — Write Off: 29966.00
EKG.V income_statement (quarterly, 2025-03-31) — +Operating Expense: 179416.00
EKG.V income_statement (quarterly, 2025-03-31) — +Total Revenue: 100041.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 54714.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 77339.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -726284.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -21702.00
EKG.V income_statement (quarterly, 2025-03-31) — Basic Average Shares: 193074006.00
EKG.V income_statement (quarterly, 2025-03-31) — Basic EPS: 0.00
EKG.V cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 64040.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 42480.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 44932.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Capital Stock: 30648685.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 39309.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 39309.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Cash Financial: 39309.00
EKG.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 73100.00
EKG.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -97831.00
EKG.V cash_flow (quarterly, 2025-03-31) — Change In Inventory: 1020.00
EKG.V cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -46256.00
EKG.V cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 20792.00
EKG.V cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -15648.00
EKG.V cash_flow (quarterly, 2025-03-31) — Change In Receivables: -46235.00
EKG.V cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -86327.00
EKG.V cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -46235.00
EKG.V cash_flow (quarterly, 2025-03-31) — Changes In Cash: -24731.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Common Stock: 30648685.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -294691.00
EKG.V income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 6388.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 48734.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Current Assets: 195578.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 24905.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Current Debt: 311000.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 335905.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 84444.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 84444.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 523797.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Current Notes Payable: 311000.00
EKG.V cash_flow (quarterly, 2025-03-31) — Depreciation: 7065.00
EKG.V cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 7065.00
EKG.V income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 7065.00
EKG.V cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 7065.00
EKG.V income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 7065.00
EKG.V income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 7065.00
EKG.V income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 193074006.00
EKG.V income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.00
EKG.V income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -18113.00
EKG.V income_statement (quarterly, 2025-03-31) — EBIT: -12169.00
EKG.V income_statement (quarterly, 2025-03-31) — EBITDA: -5104.00
EKG.V cash_flow (quarterly, 2025-03-31) — End Cash Position: 39309.00
EKG.V cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 73100.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Finished Goods: 26169.00
EKG.V cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -97831.00
EKG.V income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 23427.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 4371249.00
EKG.V income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 152507.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 99041.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Gross PPE: 779839.00
EKG.V income_statement (quarterly, 2025-03-31) — Gross Profit: 93653.00
EKG.V income_statement (quarterly, 2025-03-31) — Insurance And Claims: 22488.00
EKG.V income_statement (quarterly, 2025-03-31) — Interest Expense: 5944.00
EKG.V income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 5944.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Interest Payable: 13484.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Inventory: 26169.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Invested Capital: 16309.00
EKG.V cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 80000.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 20027.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 20027.00
EKG.V cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -6900.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 737359.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Net Debt: 271691.00
EKG.V income_statement (quarterly, 2025-03-31) — Net Income: -18113.00
EKG.V income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -18113.00
EKG.V income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -18113.00
EKG.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -18113.00
EKG.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -18113.00
EKG.V cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -18113.00
EKG.V income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -18113.00
EKG.V income_statement (quarterly, 2025-03-31) — Net Interest Income: -5944.00
EKG.V cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 73100.00
EKG.V cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -6900.00
EKG.V income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -5944.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Net PPE: 53555.00
EKG.V cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 80000.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -294691.00
EKG.V income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -28531.00
EKG.V income_statement (quarterly, 2025-03-31) — Normalized Income: -41540.00
EKG.V cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -97831.00
EKG.V income_statement (quarterly, 2025-03-31) — Operating Income: -85763.00
EKG.V income_statement (quarterly, 2025-03-31) — Operating Revenue: 100041.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 193074006.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 4371249.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 149690.00
EKG.V income_statement (quarterly, 2025-03-31) — Other Gand A: 13516.00
EKG.V income_statement (quarterly, 2025-03-31) — Other Income Expense: 73594.00
EKG.V cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -456.00
EKG.V income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 50167.00
EKG.V income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 19844.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Payables: 54714.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 103448.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 41401.00
EKG.V income_statement (quarterly, 2025-03-31) — Pretax Income: -18113.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Receivables: 88699.00
EKG.V income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 6388.00
EKG.V income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 7065.00
EKG.V cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -6900.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -35464315.00
EKG.V income_statement (quarterly, 2025-03-31) — Salaries And Wages: 116503.00
EKG.V income_statement (quarterly, 2025-03-31) — Selling General And Administration: 152507.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Share Issued: 193074006.00
EKG.V cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 80000.00
EKG.V cash_flow (quarterly, 2025-03-31) — Short Term Debt Payments: 0.00
EKG.V cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 0.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -294691.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -294691.00
EKG.V income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
EKG.V income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 11360.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Total Assets: 249133.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Total Capitalization: -294691.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Total Debt: 355932.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -294691.00
EKG.V income_statement (quarterly, 2025-03-31) — Total Expenses: 185804.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 543824.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 53555.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 20027.00
EKG.V income_statement (quarterly, 2025-03-31) — Total Unusual Items: 23427.00
EKG.V income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 23427.00
EKG.V balance_sheet (quarterly, 2025-03-31) — Working Capital: -328219.00
EKG.V income_statement (quarterly, 2025-06-30) — +Operating Expense: 203340.00
EKG.V income_statement (quarterly, 2025-06-30) — +Total Revenue: 72032.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 17941.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 62692.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -21702.00
EKG.V income_statement (quarterly, 2025-06-30) — Basic Average Shares: 193074006.00
EKG.V income_statement (quarterly, 2025-06-30) — Basic EPS: 0.00
EKG.V cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 39309.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 36411.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 38890.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Capital Stock: 30648685.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 47461.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 47461.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Cash Financial: 47461.00
EKG.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 187100.00
EKG.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -178948.00
EKG.V cash_flow (quarterly, 2025-06-30) — Change In Inventory: -780.00
EKG.V cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -51475.00
EKG.V cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -47873.00
EKG.V cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 9567.00
EKG.V cash_flow (quarterly, 2025-06-30) — Change In Receivables: 14060.00
EKG.V cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -76501.00
EKG.V cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 14060.00
EKG.V cash_flow (quarterly, 2025-06-30) — Changes In Cash: 8152.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Common Stock: 30648685.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -418953.00
EKG.V income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 16849.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 46229.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Current Assets: 175586.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 25407.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Current Debt: 505000.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 530407.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 32969.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 32969.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 627546.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Current Notes Payable: 505000.00
EKG.V cash_flow (quarterly, 2025-06-30) — Depreciation: 7064.00
EKG.V cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 7064.00
EKG.V income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 7064.00
EKG.V cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 7064.00
EKG.V income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 7064.00
EKG.V income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 7064.00
EKG.V income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 193074006.00
EKG.V income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.00
EKG.V income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -124262.00
EKG.V income_statement (quarterly, 2025-06-30) — EBIT: -115911.00
EKG.V income_statement (quarterly, 2025-06-30) — EBITDA: -108847.00
EKG.V cash_flow (quarterly, 2025-06-30) — End Cash Position: 47461.00
EKG.V cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 187100.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Finished Goods: 26949.00
EKG.V cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -178948.00
EKG.V income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 275.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 4371249.00
EKG.V income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 160284.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 84394.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Gross PPE: 773770.00
EKG.V income_statement (quarterly, 2025-06-30) — Gross Profit: 55183.00
EKG.V income_statement (quarterly, 2025-06-30) — Insurance And Claims: 17380.00
EKG.V income_statement (quarterly, 2025-06-30) — Interest Expense: 8351.00
EKG.V income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 8351.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Interest Payable: 20977.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Inventory: 26949.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Invested Capital: 86047.00
EKG.V cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 194000.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 13483.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 13483.00
EKG.V cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -6900.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 737359.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Net Debt: 457539.00
EKG.V income_statement (quarterly, 2025-06-30) — Net Income: -124262.00
EKG.V income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -124262.00
EKG.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -124262.00
EKG.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -124262.00
EKG.V cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -124262.00
EKG.V income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -124262.00
EKG.V cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 187100.00
EKG.V cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -6900.00
EKG.V income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -8351.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Net PPE: 46490.00
EKG.V cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 194000.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -418953.00
EKG.V income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -109122.00
EKG.V income_statement (quarterly, 2025-06-30) — Normalized Income: -124537.00
EKG.V cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -178948.00
EKG.V income_statement (quarterly, 2025-06-30) — Operating Income: -148157.00
EKG.V income_statement (quarterly, 2025-06-30) — Operating Revenue: 72032.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 193074006.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 4371249.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 149690.00
EKG.V income_statement (quarterly, 2025-06-30) — Other Gand A: 14016.00
EKG.V income_statement (quarterly, 2025-06-30) — Other Income Expense: 32246.00
EKG.V cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 14751.00
EKG.V income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 31971.00
EKG.V income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 35992.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Payables: 17941.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 64170.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 31834.00
EKG.V income_statement (quarterly, 2025-06-30) — Pretax Income: -124262.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Receivables: 69342.00
EKG.V income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 16849.00
EKG.V income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 7064.00
EKG.V cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -6900.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -35588577.00
EKG.V income_statement (quarterly, 2025-06-30) — Salaries And Wages: 128888.00
EKG.V income_statement (quarterly, 2025-06-30) — Selling General And Administration: 160284.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Share Issued: 193074006.00
EKG.V cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: 194000.00
EKG.V cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: 0.00
EKG.V cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 0.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -418953.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -418953.00
EKG.V income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 6650.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Total Assets: 222076.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -418953.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Total Debt: 543890.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -418953.00
EKG.V income_statement (quarterly, 2025-06-30) — Total Expenses: 220189.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 641029.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 46490.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 13483.00
EKG.V income_statement (quarterly, 2025-06-30) — Total Unusual Items: 275.00
EKG.V income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 275.00
EKG.V balance_sheet (quarterly, 2025-06-30) — Working Capital: -451960.00
EKG.V income_statement (quarterly, 2025-09-30) — +Operating Expense: 214695.00
EKG.V income_statement (quarterly, 2025-09-30) — +Total Revenue: 44074.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 26614.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 140931.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -728275.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -26702.00
EKG.V income_statement (quarterly, 2025-09-30) — Basic Average Shares: 195818511.00
EKG.V income_statement (quarterly, 2025-09-30) — Basic EPS: 0.00
EKG.V cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 47461.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 30342.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 32727.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Capital Stock: 30690310.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 24708.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 24708.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Cash Financial: 24708.00
EKG.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 99100.00
EKG.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -121853.00
EKG.V cash_flow (quarterly, 2025-09-30) — Change In Inventory: 1666.00
EKG.V cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 46793.00
EKG.V cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 68489.00
EKG.V cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 14247.00
EKG.V cash_flow (quarterly, 2025-09-30) — Change In Receivables: -78239.00
EKG.V cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 52956.00
EKG.V cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -78239.00
EKG.V cash_flow (quarterly, 2025-09-30) — Changes In Cash: -22753.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Common Stock: 30690310.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -567737.00
EKG.V income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2645.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 55825.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Current Assets: 216810.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 25918.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Current Debt: 611000.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 636918.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 97807.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 97807.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 817164.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Current Notes Payable: 611000.00
EKG.V cash_flow (quarterly, 2025-09-30) — Depreciation: 7064.00
EKG.V cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 7064.00
EKG.V income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 7064.00
EKG.V cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 7064.00
EKG.V income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 7064.00
EKG.V income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 7064.00
EKG.V income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 195818511.00
EKG.V income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.00
EKG.V income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -169778.00
EKG.V income_statement (quarterly, 2025-09-30) — EBIT: -156442.00
EKG.V income_statement (quarterly, 2025-09-30) — EBITDA: -149378.00
EKG.V cash_flow (quarterly, 2025-09-30) — End Cash Position: 24708.00
EKG.V cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 99100.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Finished Goods: 25283.00
EKG.V cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -121853.00
EKG.V income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -15147.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 4371249.00
EKG.V income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 183471.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 167633.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Gross PPE: 767701.00
EKG.V income_statement (quarterly, 2025-09-30) — Gross Profit: 41429.00
EKG.V income_statement (quarterly, 2025-09-30) — Insurance And Claims: 22937.00
EKG.V income_statement (quarterly, 2025-09-30) — Interest Expense: 13336.00
EKG.V income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 13336.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Interest Payable: 28776.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Inventory: 25283.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Invested Capital: 43263.00
EKG.V cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 106000.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 6809.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 6809.00
EKG.V cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -6900.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 737359.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Net Debt: 586292.00
EKG.V income_statement (quarterly, 2025-09-30) — Net Income: -169778.00
EKG.V income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -169778.00
EKG.V income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -169778.00
EKG.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -169778.00
EKG.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -169778.00
EKG.V cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -190409.00
EKG.V income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -169778.00
EKG.V income_statement (quarterly, 2025-09-30) — Net Interest Income: -13336.00
EKG.V cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 99100.00
EKG.V cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -6900.00
EKG.V income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -13336.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Net PPE: 39426.00
EKG.V cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 106000.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -567737.00
EKG.V income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -134231.00
EKG.V income_statement (quarterly, 2025-09-30) — Normalized Income: -154631.00
EKG.V cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -121853.00
EKG.V income_statement (quarterly, 2025-09-30) — Operating Income: -173266.00
EKG.V income_statement (quarterly, 2025-09-30) — Operating Revenue: 44074.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 197236506.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 4371249.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 149690.00
EKG.V income_statement (quarterly, 2025-09-30) — Other Gand A: 18974.00
EKG.V income_statement (quarterly, 2025-09-30) — Other Income Expense: 16824.00
EKG.V cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 8536.00
EKG.V income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 31971.00
EKG.V income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 24160.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Payables: 26614.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 82439.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 17587.00
EKG.V income_statement (quarterly, 2025-09-30) — Pretax Income: -169778.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Receivables: 149232.00
EKG.V income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2645.00
EKG.V income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 7064.00
EKG.V cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -6900.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -35778986.00
EKG.V income_statement (quarterly, 2025-09-30) — Salaries And Wages: 141560.00
EKG.V income_statement (quarterly, 2025-09-30) — Selling General And Administration: 183471.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Share Issued: 197236506.00
EKG.V cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: 106000.00
EKG.V cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: 0.00
EKG.V cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 0.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -567737.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -567737.00
EKG.V income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
EKG.V income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 8301.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Total Assets: 256236.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -567737.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Total Debt: 643727.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -567737.00
EKG.V income_statement (quarterly, 2025-09-30) — Total Expenses: 217340.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 823973.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 39426.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 6809.00
EKG.V income_statement (quarterly, 2025-09-30) — Total Unusual Items: -15147.00
EKG.V income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -15147.00
EKG.V balance_sheet (quarterly, 2025-09-30) — Working Capital: -600354.00
EKG.V income_statement (annual, 2025-12-31) — +Operating Expense: 778873.00
EKG.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 181422.00
EKG.V income_statement (annual, 2025-12-31) — +Total Revenue: 272158.00
EKG.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 56011.00
EKG.V balance_sheet (annual, 2025-12-31) — Accounts Payable: 33036.00
EKG.V balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 33036.00
EKG.V balance_sheet (annual, 2025-12-31) — Accounts Receivable: 41432.00
EKG.V balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 41432.00
EKG.V balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -729684.00
EKG.V balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -729684.00
EKG.V balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -45826.00
EKG.V balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -45826.00
EKG.V income_statement (annual, 2025-12-31) — Basic Average Shares: 194862348.00
EKG.V income_statement (annual, 2025-12-31) — Basic EPS: 0.00
EKG.V cash_flow (annual, 2025-12-31) — Beginning Cash Position: 64040.00
EKG.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 24708.00
EKG.V balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 24274.00
EKG.V balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 24274.00
EKG.V cash_flow (annual, 2025-12-31) — Capital Expenditure: -2505.00
EKG.V balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 26440.00
EKG.V balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 26440.00
EKG.V balance_sheet (annual, 2025-12-31) — Capital Stock: 30693766.00
EKG.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 30693766.00
EKG.V balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 47043.00
EKG.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 47043.00
EKG.V balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 47043.00